Top 34 Nohla Therapeutics investors
The most complete profiles first. Showing 34 of 34.
Andy SchwabVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more
Verified email available
Brian DanielsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Deborah PalestrantVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Jason RuthVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Lou TartagliaVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Verified email available
Rebecca ChenVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Elliot EhrichVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Jay SongVerified
Hedge Fund, Venture Capital, Private Equity Firm
Health CareE-commerceComputer VisionWomen FoundedPortfolio: Chain Partners, Bespin Global, B2Link, Nohla Therapeutics and 10 more
Verified email available
Jonathan WeissmanVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Paul StoneVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Seong KimVerified
Hedge Fund, Venture Capital · South Korea
Health CareE-commerceComputer VisionWomen FoundedPortfolio: Chain Partners, Bespin Global, B2Link, Nohla Therapeutics and 10 more
Verified email available
SungVerified
Hedge Fund, Venture Capital · South Korea
Health CareE-commerceComputer VisionWomen FoundedPortfolio: Chain Partners, Bespin Global, B2Link, Nohla Therapeutics and 10 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Jamil M. Beg
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
John Diekman
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Mason Freeman
Venture Capital, Investor · United States
SeedHealth CareHospitalsGeneticsLife SciencePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mira Chaurushiya
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsAlternative MedicineAndroidPortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Scott Rocklage
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Donghoon Lee
Hedge Fund, Venture Capital · South Korea
Health CareE-commerceComputer VisionWomen FoundedPortfolio: Chain Partners, Bespin Global, B2Link, Nohla Therapeutics and 10 more
Contact details available
Hideki Tsuji
Venture Capital, University Program · Japan
Portfolio: Vegetalia, Seven Dreamers Laboratories, EditForce, AI inside and 62 more
Contact details available
Jonathan Kabakoff
Corporate Venture Capital · United States
Health CareWomen FoundedChemicalLife SciencePortfolio: Molecular Assemblies, Syros Pharmaceuticals, EpiBiome, Immunitas Therapeutics and 30 more
Contact details available
Joseph Victor
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Maiko Katadae
Venture Capital, University Program · Japan
Portfolio: Vegetalia, Seven Dreamers Laboratories, EditForce, AI inside and 62 more
Contact details available
Peter Kim
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Ted Yamamoto
Venture Capital, University Program · Japan
Portfolio: Vegetalia, Seven Dreamers Laboratories, EditForce, AI inside and 62 more
Contact details available
Tomotaka Goji, PhD
Venture Capital, University Program, Private Equity Firm · Japan
Media and EntertainmentPortfolio: Vegetalia, Seven Dreamers Laboratories, EditForce, AI inside and 62 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Nohla Therapeutics investors are on Angel Roster?
Angel Roster lists 34 Nohla Therapeutics investors. 15 of them (44%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (33), Private Equity Firms (13) and Hedge Funds (4). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Nohla Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (11) and Series B (6).
Where are Nohla Therapeutics investors based?
Most are based in the United States (25), Japan (4) and South Korea (3).
Which companies have Nohla Therapeutics investors backed?
The most-backed portfolio companies among them are Homology Medicines (25), Pulmatrix (16), Arvinas (16), Purigen Biosystems (16) and Impel NeuroPharma (16).
How do I contact Nohla Therapeutics investors?
Create a free Angel Roster account to search and filter all 34, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.